<DOC>
	<DOCNO>NCT02244073</DOCNO>
	<brief_summary>During last 2 decade , management hyperglycemia critically ill patient become one discussed topic intensive-care field . The initial data suggest significant benefit normalization blood glucose level critically ill patient use intensive intravenous insulin therapy ( Van den Berghe G et al . N Engl J Med . 2001 ) temper late study ( Finfer S et al . N Engl J Med . 2009 ) . Some study suggest strict blood glucose control might benefit non-diabetic patient worsen outcomes diabetic . We hypothesize individualized blood glucose target base glycated hemoglobin measure ICU admission would improve outcome compare standard care maintain blood glucose bellow 10 mmol/l ( 180 mg/dl ) . We design randomize double blind study Blood glucose control pilot group web-guided protocol directly give instruction nurse ( http : //extranet.chu-lyon.fr/cpg ) . The study enroll 4200 patient 10 center . Primary end point 90 outcome randomization .</brief_summary>
	<brief_title>Individualized Blood Glucose Control ICU . The CONTROLING Study . A Double Blinded Multicentric Randomized Study .</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Patients eligible INCLUSION study ALL follow criterion meet : Patient 18 year old older ; At time patient 's admission ICU treat ICU specialist expect patient require treatment ICU extend beyond calendar day follow day admission . Patients EXCLUDED study ONE MORE follow criteria present : Patient legal surrogate decision maker accept participation study ; Imminent death ( anticipate less 48 hour ) ; The treating clinician commit full supportive care ( resuscitation , renal replacement therapy limit dose vasoactive support ) ; Patient expect eating end day follow admission ; Admission ICU hypoglycemic encephalopathy patient risk hypoglycaemia ( e.g . know insulin secrete tumour history unexplained recurrent hypoglycaemia fulminant hepatic failure ) ; If patient previously enrol CONTROLING Study ( patient enrol CONTROLING Study ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>blood glucose target</keyword>
	<keyword>ICU</keyword>
	<keyword>insulin</keyword>
	<keyword>hypoglycemia</keyword>
	<keyword>hyperglycemia</keyword>
	<keyword>glycated hemoglobin</keyword>
</DOC>